Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02865187 · ClinicalTrials.gov registry record · NA
Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
A NA study of Polycystic Ovary Syndrome and Female Sexual Dysfunction, sponsored by Wright State University.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 2
- Study locations
NCT02865187: Completed NA study of Polycystic Ovary Syndrome and Female Sexual Dysfunction, sponsored by Wright State University.
NCT02865187 is a NA study of Polycystic Ovary Syndrome and Female Sexual Dysfunction that has completed, run by Wright State University. The registered enrollment target is 47 participants, below the 17,256-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02865187, a NA study of Polycystic Ovary Syndrome and Female Sexual Dysfunction, has completed, sponsored by Wright State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 2
- Study locations
Study Summary
SUMMARY: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive age women with a prevalence as high as 15%. The clinical symptoms of PCOS including menstrual dysfunction, infertility, hirsutism, alopecia, acne, and the possible increased risk of diabetes and cardiovascular disease have been reported to be significant contributors to psychological morbidity and impact health-related quality of life. For women with PCOS, the changes in physical appearance and the associated mood disorders appear to be deleterious for sexual function. Vitamin D deficiency (\<20 ng/ml serum concentration of 25\[OH\]D), which affects from 67% to 85% of women,4 is closely linked to symptoms of PCOS. The main physiologic role of vitamin D is to regulate calcium and phosphorus homeostasis and to promote bone health. Although there has been an increase in awareness of the importance of sexual dysfunction and QoL in women with PCOS, few studies have evaluated the outcomes of treatment for PCOS upon sexual and subjective health status of women. The goals of this study are: 1. To evaluate the prevalence of sexual dysfunction (SDy) in women with Polycystic Ovarian Syndrome (PCOS) 2. To determine the effects of Vitamin D therapy, with and without hormonal contraceptives, on SDy in women with PCOS in the absence of depression. METHODS: The study will enroll 60 women diagnosed with PCOS and reporting SDy at the Wright State Physicians (WSP) OB-GYN Practice and the WSP Family Medicine Practice. All participants will take vitamin D 600IU/day and will choose between hormonal and non-hormonal contraceptive methods (target of 30 participants in each group). Participants will complete three study visits (Initial, Month 3, and Month 6). Vitamin D levels will be drawn at the beginning of the study and again at 3 and 6 months after initiation of vitamin D therapy. Each participant will be asked to complete the Female Sexual Function Index (FSFI) and the Beck Depress
Primary Outcome
Female Sexual Function Index (FSFI) scores at Month 6 (Total score ranges from 2 - 36; scores less than 26.55 represent presence/degree of sexual dysfunction)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D
- DRUG Hormonal contraception
Study Locations (2)
Ohio
- Wright State Physicians - Dayton
Pennsylvania
- Pennsylvania State University - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-02-06 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
What the finished NCT02865187 record still lists
NCT02865187 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 17,256-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Polycystic Ovary Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Vitamin D is the first listed.
NCT02865187 reports a single indexed study location in Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02865187 about?
NCT02865187 is a clinical study titled "Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction". SUMMARY: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive age women with a prevalence as high as 15%. The clinical symptoms of PCOS including menstrual dysfunction, infertility, hirsutism, alopecia, acne, and the possible increased risk of diabetes and cardi...
What is the current status of trial NCT02865187?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2017-02-06. Estimated completion is 2020-12-31.
What conditions does trial NCT02865187 study?
This clinical trial studies the following conditions: Polycystic Ovary Syndrome, Female Sexual Dysfunction.
What interventions are being tested in trial NCT02865187?
The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT), Hormonal contraception (DRUG).
Who is sponsoring clinical trial NCT02865187?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02865187 being conducted?
This trial has 2 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycystic Ovary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02865187's enrollment target sits among peer trials
47 17th of 30 higher than 13 of 30 other Polycystic Ovary Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Polycystic Ovary Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
RECRUITING · NA
-
IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer
RECRUITING · NA
-
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
RECRUITING · NA
-
Myo-Inositol for Infertility in PCOS
RECRUITING · NA
-
Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial
ACTIVE NOT RECRUITING · NA
-
A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic Ovary Syndrome
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI